SUMO1 and liver cancer: Conversely, p300 knockdown effectively abolished Ubc9/SUMO1-induced PEPCK1 sumoylation (Supplementary Fig. 4a, left), thus enhancing PEPCK1 expression in different liver cancer cells (Supplementary Fig. 4a, right).